Stars from Film, Television, Sports, Journalism and Music Come ... 1888 Press Release (press release), TX - ... Friends of Cancer Research, Intercultural Cancer Council, Leukemia & Lymphoma Society, Lung Cancer Alliance, The Multiple Myeloma Research Foundation, ...
New study backs solvent, leukemia link Reuters - Nov 18, 2008 It is understood to cause acute myeloid leukemia, but its association with multiple myeloma and chronic lymphoid leukemia risk "are still under debate," ...
Source: Google News
Recent News and Articles on the Keywords: multiple myeloma + new + myeloma Related to the article below (Last Update: 8/7/2008)
Cancer Researchers And Oncologists Offer A Clinical Trial For ... Medical News Today (press release), UK - Aug 6, 2008 "Cancer, in particular, needs some new ideas since the old approaches aren't working." Multiple myeloma is a treatable progressive disease that attacks the ...
GMU Proteomics Partners with Virginia Clinic on Myeloma Study GenomeWeb News (subscription), NY - The University?s Center for Applied Proteomics and Molecular Medicine will use funding from the Chris Walker Multiple Myeloma Foundation to work with the ...
Treatment With Anti-anemia Drugs May Not Be Safe For Multiple... Science Daily (press release) - Aug 4, 2008 In the study, 323 multiple myeloma patients were evaluated over a 20 year period in Greece from 1988 to 2007. The investigators reviewed their medical ...
How Molecules Out Of Balance Lead To Human Multiple Myeloma And ... Science Daily (press release) - Jul 29, 2008 ScienceDaily (July 28, 2008) ? An international team of scientists has identified processes that are heavily implicated in human multiple myeloma and other ...
New spots to cater to patients at campsite Arkansas Democrat Gazette, AR - Aug 4, 2008 It took six months to get a diagnosis of multiple myeloma, or cancer of the plasma cells. Doctors found lesions in his pelvis, sternum, spine and skull. ...
Neighbor in need Russellville Courier, AR - Aug 4, 2008 In April 1999, doctors diagnosed Richardson with multiple myeloma, a cancer which attacks plasma cells. According to the Multiple Myeloma Research ...
Louis Brilliant, former Bethany official, dies at 74 The News Journal, DE - Memorials may be made to the Hospice of Palm Beach County, 1901 S. Congress Ave., Suite 200, Boynton Beach, or the International Myeloma Foundation, ...
Board honors the late Raymond Durant Fenton Tri County Times, MI - Durant passed away on July 14 after a long and courageous battle with multiple myeloma. In 1976, Durant started his own ice cream business, ...
Source: Google News
Antitumor activity of thalidomide in refractory multiple myeloma - S Singhal, J Mehta, R Desikan, D Ayers, P Roberson … - New England Journal of Medicine, 1999 - content.nejm.org ... CA Cancer J Clin 51: 273-285 [Abstract] [Full Text]; Durie, BGM (2001). Multiple Myeloma: What's New. ...MultipleMyeloma: New Insights and Therapeutic Approaches. ...
Plasma cell myeloma--new biological insights and advances in therapy. - B Barlogie, J Epstein, P Selvanayagam, R Alexanian - Blood, 1989 - ncbi.nlm.nih.gov ... provide important clues about the ontogeny of multiplemyeloma. Myeloma cells express
many receptors for different ... with the use of new quantitative parameters ...
Bone marrow angiogenesis and progression in multiple myeloma - A Vacca, D Ribatti, L Roncali, G Ranieri, G Serio, … - British Journal of Haematology, 1994 - Blackwell Synergy ... 1994. 87, 503-508 Bone marrow angiogenesis and progression in multiplemyeloma...
Keywords: multiplemyeloma, MGUS, angiogenesis, bone marrow. ...
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma - PG Richardson, P Sonneveld, MW Schuster, D Irwin, … - New England Journal of Medicine, 2005 - content.nejm.org ...New Drugs for Myeloma. ... Patterns of Survival in MultipleMyeloma: A Population-
Based Study of Patients Diagnosed in Sweden From 1973 to 2003. ...
[PDF]Multiple myeloma - RA Kyle, SV Rajkumar - Blood, 2008 - bloodjournal.hematologylibrary.org ... For ex- ample, Rosenthal and Vogel 15 reported that only 3 cases of multiplemyeloma
had been recognized in Mount Sinai Hospital in New York from 1916 to 1935 ... -
Multiple Myeloma - R Bataille, JL Harousseau - New England Journal of Medicine, 1997 - content.nejm.org ... Blood 98: 2229-2238 [Abstract] [Full Text]; Zaidi, AA, Vesole, DH (2001). Multiple Myeloma: An Old Disease with New Hope for the Future. ...
The US Food and Drug Administration has approved a new use for the drug Revlimid (lenalidomide). It will now be available to people with multiple myeloma that has not responded to other treatments. The drug is already approved to treat a certain type of myelodysplastic syndrome, a bone marrow disorder that can sometimes lead to leukemia.
Revlimid, made by Celgene Corporation, is given along with the steroid drug dexamethasone. In 2 clinical trials, this combination was better than dexamethasone alone in delaying cancer progression. Patients on Revlimid plus dexamethasone went about 37 weeks before their cancer started growing again, compared to 20 weeks for those on dexamethasone alone.
Multiple myeloma causes plasma cells in the blood to grow out of control. The disease is expected to strike about 16,500 people in the US in 2006 and kill more than 11,000. Standard treatment often includes chemotherapy and stem cell transplant. The drug thalidomide is also used.
Revlimid is similar to thalidomide. Because both drugs can cause severe birth defects, their use is strictly monitored, and patients of childbearing age must agree to use birth control measures to assure they do not become pregnant or cause a pregnancy during treatment.
Revlimid can also have other severe side effects, including low white blood cell count (neutropenia) and low platelet count (thrombocytopenia). The drug also raises the risk of blood clots in the legs and lungs. Less serious side effects may include constipation, fatigue, muscle cramps, and diarrhea.
